Successful treatment of COVID-19-related acute respiratory distress syndrome with rare blood type: A case report

Hiroyuki Yamada, MD^1,2, Shigeru Ohtsuru, MD¹, Mika Nagatomo, MD¹, Yohei Korogi, MD³, Ken Shinozuka, MD¹, Naoya Tanabe, MD³, Shinichi Kai, MD⁴, Takeshi Matsubara, MD²,

Isao Ito, MD³, Masahiro Ihara, MD⁵, Tomoharu Tanaka, MD⁴, Genta Kato, MD⁶,

Miki Nagao, MD⁷, Hiroshi Date, MD⁸

¹Department of Primary Care and Emergency Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

²Department of Nephrology, Graduate School of Medicine, Kyoto University, Kyoto, Japan

³Department of Reparatory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

⁴Department of Anesthesia, Graduate School of Medicine, Kyoto University, Kyoto, Japan

⁵Department of Medical Informatics, Graduate School of Medicine, Kyoto University, Kyoto

⁶Solutions Center for Health Insurance Claims, Kyoto University Hospital

⁷Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan

⁸Department of Thoracic Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan

Keywords: ECMO, Rhesus, hydrocortisone, COVID-19, ARDS, AKI

*Correspondence: Shigeru Ohtsuru, MD, PhD

54 Shogoin-kawaharacho, Sakyo-ku, Kyoto 6068507, Japan

Phone: +81-75-751-3126

Fax: +81-75-751-4255

Email: ohtsuru@kuhp.kyoto-u.ac.jp